This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arlt, M. J.E. Articles by Krüger, A. Search for Related Content PubMed PubMed Citation Articles by Arlt, M. J.E. Articles by Krüger, A.

Efficient Inhibition of Intra-Peritoneal Tumor Growth and Dissemination of Human Ovarian Carcinoma Cells in Nude Mice by Anti-L1-Cell Adhesion Molecule Monoclonal Antibody Treatment

¹ Klinikum rechts der Isar der Technischen Universität München, Institut für Experimentelle Onkologie und Therapieforschung, Munich, Germany; ² Center for Radiopharmaceutical Science ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland; and ³ Tumor Immunology Programme, D010 and D050, German Cancer Research Center, Heidelberg, Germany

Requests for reprints: Achim Krüger, Klinikum rechts der Isar der Technischen Universität München, Institut für Experimentelle Onkologie und Therapieforschung, Ismaninger Str. 22, D-81675 Munich, Germany. Phone: 49-89-4140-4463; Fax: 49-89-4140-6182; E-mail: achim.krueger{at}lrz.tu-muenchen.de.

The L1 cell adhesion molecule is implicated in the control of proliferation, migration, and invasion of several tumor cell types in vitro. Recently, L1 overexpression was found to correlate with tumor progression of ovarian carcinoma, one of the most common causes of cancer-related deaths in gynecologic malignant diseases. To evaluate L1 as a potential target for ovarian cancer therapy, we investigated the effects of anti-L1 monoclonal antibodies (chCE7 and L1-11A) on proliferation and migration of L1-positive human SKOV3ip ovarian carcinoma cells in vitro and the therapeutic efficacy of L1-11A against i.p. SKOV3ip tumor growth in nude mice. In vitro, both anti-L1 antibodies efficiently inhibited the proliferation of SKOV3ip cells as well as other L1-expressing tumor cell lines (renal carcinoma, neuroblastoma, and colon carcinoma). On two cell lines, hyper-cross-linking of L1-11A with a secondary antibody was necessary for significant inhibition of proliferation, indicating that cross-linking of L1 is required for the antiproliferative effect. L1-negative prostate carcinoma cells were not influenced by antibody treatment. Biweekly treatment of ovarian carcinoma-bearing mice with L1-11A led to a dose-dependent and significant reduction of tumor burden (up to –63.5%) and ascites formation (up to –75%). This effect was associated with reduced proliferation within the tumors. L1-directed antibody-based inhibition of peritoneal growth and dissemination of human ovarian carcinoma cells represents important proof-of-principle for the development of a new therapy against one of the leading gynecologic malignant diseases. (Cancer Res 2006; 66(2): 936-43)

This article has been cited by other articles:

				S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R. E. McLendon, A. B. Hjelmeland, and J. N. Rich Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth Cancer Res., August 1, 2008; 68(15): 6043 - 6048. [Abstract] [Full Text] [PDF]

				J. W.J. van Kilsdonk, R. H. Wilting, M. Bergers, G. N.P. van Muijen, J. Schalkwijk, L. C.L.T. van Kempen, and G. W.M. Swart Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule Cancer Res., May 15, 2008; 68(10): 3671 - 3679. [Abstract] [Full Text] [PDF]

				D. Finas, M. Huszar, A. Agic, S. Dogan, H. Kiefel, S. Riedle, D. Gast, R. Marcovich, F. Noack, P. Altevogt, et al. L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis Hum. Reprod., May 1, 2008; 23(5): 1053 - 1062. [Abstract] [Full Text] [PDF]

				M. Zhao, P. Szafranski, C. A. Hall, and S. Goode Basolateral Junctions Utilize Warts Signaling to Control Epithelial-Mesenchymal Transition and Proliferation Crucial For Migration and Invasion of Drosophila Ovarian Epithelial Cells Genetics, April 1, 2008; 178(4): 1947 - 1971. [Abstract] [Full Text] [PDF]

				S. Zecchini, M. Bianchi, N. Colombo, R. Fasani, G. Goisis, C. Casadio, G. Viale, J. Liu, M. Herlyn, A. K. Godwin, et al. The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium Cancer Res., February 15, 2008; 68(4): 1110 - 1118. [Abstract] [Full Text] [PDF]

				O. Rosso, T. Piazza, I. Bongarzone, A. Rossello, D. Mezzanzanica, S. Canevari, A. M. Orengo, A. Puppo, S. Ferrini, and M. Fabbi The ALCAM Shedding by the Metalloprotease ADAM17/TACE Is Involved in Motility of Ovarian Carcinoma Cells Mol. Cancer Res., December 1, 2007; 5(12): 1246 - 1253. [Abstract] [Full Text] [PDF]

				M. Tanaka, R. Kamata, M. Takigahira, K. Yanagihara, and R. Sakai Phosphorylation of Ephrin-B1 Regulates Dissemination of Gastric Scirrhous Carcinoma Am. J. Pathol., July 1, 2007; 171(1): 68 - 78. [Abstract] [Full Text] [PDF]

				Y.-J. Boo, J.-M. Park, J. Kim, Y.-S. Chae, B.-W. Min, J.-W. Um, and H.-Y. Moon L1 Expression as a Marker for Poor Prognosis, Tumor Progression, and Short Survival in Patients with Colorectal Cancer Ann. Surg. Oncol., May 1, 2007; 14(5): 1703 - 1711. [Abstract] [Full Text] [PDF]

				K. Knogler, J. Grunberg, K. Zimmermann, S. Cohrs, M. Honer, S. Ametamey, P. Altevogt, M. Fogel, P. A. Schubiger, and I. Novak-Hofer Copper-67 Radioimmunotherapy and Growth Inhibition by Anti-L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis Clin. Cancer Res., January 15, 2007; 13(2): 603 - 611. [Abstract] [Full Text] [PDF]

				M. Shtutman, E. Levina, P. Ohouo, M. Baig, and I. B. Roninson Cell Adhesion Molecule L1 Disrupts E-Cadherin-Containing Adherens Junctions and Increases Scattering and Motility of MCF7 Breast Carcinoma Cells Cancer Res., December 1, 2006; 66(23): 11370 - 11380. [Abstract] [Full Text] [PDF]